Skip to main content

Advertisement

Log in

Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease

  • Comment
  • Published:

From Nature Cardiovascular Research

View current issue Submit your manuscript
  • 6 Altmetric

Although anti-inflammatory drugs have shown promising results in preclinical cardiovascular research, they have yielded little benefit in clinical trials. Before we can expect positive outcomes, we need to find ways of stratifying patients based on their infectious, inflammatory and autoimmune profile, and identify the right time of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Finding the right balance.

References

  1. Everett, B. M. et al. Am. Heart J. 166, 199–207.e15 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Tardif, J.-C. et al. N. Engl. J. Med. 381, 2497–2505 (2019).

    Article  CAS  PubMed  Google Scholar 

  4. Abbate, A. et al. Am. J. Cardiol. 111, 1394–1400 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Schulz, T. F. Int. J. Cancer 125, 1755–1763 (2009).

    Article  CAS  PubMed  Google Scholar 

  6. Ridker, P. M. et al. Lancet 390, 1833–1842 (2017).

    Article  CAS  PubMed  Google Scholar 

  7. Kreiner, E. et al. J. Allergy Clin. Immunol. 140, 771–781 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. Piché, M.-E., Tchernof, A. & Després, J.-P. Circ. Res. 126, 1477–1500 (2020).

    Article  PubMed  Google Scholar 

  9. Ridker, P. M. Lancet 391, 319–328 (2018).

    Article  CAS  PubMed  Google Scholar 

  10. Abplanalp, W. et al. Eur. Heart J. 44, (2023).

  11. Rieckmann, M. et al. J. Clin. Invest. 129, 4922–4936 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sattler, S. ESC Hear. Fail. https://doi.org/10.1002/ehf2.14636 (2023).

    Article  Google Scholar 

  13. Mallat, Z. & Binder, C. J. Nat. Cardiovasc. Res. 1, 431–444 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sicklinger, F. et al. Circ. Res. 127, 1214–1216 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Forte, E. et al. J. Cell. Mol. Med. 25, 229–243 (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The thoughts presented in this Comment have been refined through many conversations with like-minded fellow cardioimmunologists. In particular, I would like to acknowledge G. Campos Ramos, M. Kallikourdis and P. Alcaide. This work was supported by funding from the Austrian Science Fund (P36588-B), the British Heart Foundation (P84083), and the Leducq Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanne Sattler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sattler, S. Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease. Nat Cardiovasc Res 3, 245–247 (2024). https://doi.org/10.1038/s44161-024-00440-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-024-00440-0

  • Springer Nature Limited

Navigation